Reuters logo
BRIEF-Prothena to initiate mid-stage trial of its Parkinson's drug
July 5, 2017 / 8:21 PM / 3 months ago

BRIEF-Prothena to initiate mid-stage trial of its Parkinson's drug

July 5 (Reuters) - Prothena Corporation Plc-

* Prothena announces initiation of phase 2 PASADENA study of prx002/rg7935 in patients with early Parkinson’s disease

* Prothena Corporation Plc says to receive $30 million milestone payment under collaboration agreement with Roche Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below